CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
ASSETS
Cash and cash equivalents, $4,976 reserved at September 30, 2012	$ 11,355	$ 13,778
Other current assets	330	758
Total current assets	11,685	14,536
Patent license rights, net	1,019	0
Furniture and equipment, net	28	160
Total assets	12,732	14,696
LIABILITIES AND EQUITY
Accounts payable	209	77
Accrued compensation	1	13
Other accrued liabilities	4	29
Total current liabilities	214	119
Equity
Common Stock $.0005 par value; 100,000,000 shares authorized; 40,885,411 shares in 2012 and 40,775,411shares in 2011 issued and outstanding	20	20
Additional paid-in capital	189,178	189,074
Accumulated deficit ($149,395 at September 30, 2012 and $146,755 at December 31, 2011, accumulated during development stage period)	(177,157)	(174,517)
Total Capstone Therapeutics Corp. stockholders' equity	12,041	14,577
Noncontrolling interest	477	0
Total equity	12,518	14,577
Total liabilities and equity	$ 12,732	$ 14,696